SEVERE HUNTER DISEASE: ABOUT A CASE
- Pediatric Radiology Department, Pediatric Hospital -Rabat University Hospital Center, Faculty of Medecine and Pharmacy-Mohamed V University - Rabat.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Hunters disease is a rare genetic disorder caused by the abnormal buildup of compounds called glycoaminoglycans (or mucopolysaccharides) in body cells. There is a range of clinical forms ranging from severe forms (type A), with early intellectual impairment, to moderate forms (type B) with little or no intellectual impact. Its prognosis is reserved given the notion of multisystemic failure. The diagnosis is based on the dosage of high urinary glycosaminoglycans and the dosage of the collapsed iduronate-2-sulfatase activity. Brain magnetic resonance imaging allows early detection of lesions indicative of cranial damage. Management is based on enzyme replacement therapy and on hematopoietic stem cell transplantation. It delays clinical manifestations and improves the quality of life for patients. We report the case of a boy with this pathology in his severe form.
- Wilkinson?FL, Holley?RJ, Langford-Smith?KJ, et?al. Neuropathology in mouse models of mucopolysaccharidosis type?I, IIIA and IIIB. PLoS One 2012;7:e35787.
- Matheus?MG, Castillo?M, Smith?JK, et?al. Brain MRI findings in patients with mucopolysaccharidosis types?I and?II and mild clinical presentation. Neuroradiology 2004;46:666-72
- Fraser?J, Gason?AA, Wraith?JE, et?al. Sleep disturbance in Sanfilippo syndrome : a parental questionnaire study. Arch Dis Child 2005 ;90 :1239-42
- Martin?R, Beck?M, Eng?C, et?al. Recognition and diagnosis of mucopolysaccharidosis?II (Hunter syndrome). Pediatrics 2008 ;121 : E377-86
- Holt?JB, Poe?MD, Escolar?ML. Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics 2011 ; 127 : E1258-65.
- Fan?Z, Styner?M, Muenzer?J, et?al. Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II. AJNR Am J Neuroradiol 2010 ;31 :1319-23.
- Frawley?G, Fuenzalida?D, Donath?S, et?al. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses. Paediatr Anaesth 2012;22:737-44.
- Scriver?CR, Beaudet?AL, Sly?WS, et?al. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001:3421-52.
- Frederick Quiney, Rouin Amirfeyz, Sarah Smithson, Martin Gargan, Fergal Monsell. The mucopolysaccaridoses. Orthopaedics and Trauma (2012) 26:1, 60-63. 2012 Elsevier Ltd. All rights reserved.
- Shawky RM, Abd El-Monim MT, El-Sebai AA, El-Sayed SM. Cardiac and ocular manifestations in Egyptian patients with mucopolysaccharidoses. Eastern Med Health J 2001;7(6):981?91.
- Aldenhoven M, Sakkers RJ, Boelens J, et al. Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis 2009;68:1659?65.
- Stephan vom Dahl, Eugen Mengel. Lysosomal storage diseases as differential diagnosis of h?patospl?nom?galie. Best Practice & Research Clinical Gastroenterology 24 (2010) 619 ? 628.
- Marianne S. Muhlebach, William Wooten, Joseph Muenzer. Respiratory Manifestations in Mucopolysaccharidoses. Paediatric Respiratory Reviews 12 (2011) 133?138.
- Vinod K. Prasad and Joanne Kurtzberg. Transplant Outcomes in Mucopolysaccharidoses. Seminars in Hematology; Vol 47, N?: 1, January 2010, p (59 ? 69).
- Guffon?N, Bin-Dorel?S, Decullier?E, et?al. Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study. J Pediatr 2011;159:838-44.
- Muenzer?J, Bodamer?O, Burton?B, et?al. The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus. Eur J Pediatr 2012;171: 181-8.
[Souad Maher, Siham El Haddad, Nazik Allali and Latifa Chat (2020); SEVERE HUNTER DISEASE: ABOUT A CASE Int. J. of Adv. Res. 8 (Mar). 247-251] (ISSN 2320-5407). www.journalijar.com
Radiologie
